Nithin James, MD
Hospitalist · Reno, NVNPI 1790218857
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $248 and has fallen 71.5% since, to $71 in 2025.
Across 26 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$90
- La Jolla Pharmaceutical Company$84
- AbbVie$67
- Johnson & Johnson$63
- Boehringer Ingelheim$56
- Stryker$31
- plus $77 from 4 others
What the payments were for
- Food & beverage$469100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $90 |
| La Jolla Pharmaceutical Company | 5 | $84 |
| AbbVie | 4 | $67 |
| Johnson & Johnson | 4 | $63 |
| Boehringer Ingelheim | 2 | $56 |
| Stryker | 1 | $31 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Boston Scientific | 1 | $20 |
| Novartis | 1 | $18 |
| Enterra Medical, Inc. | 1 | $16 |
How this compares
$469 in reported general payments places this provider in the 80th percentile of 191 hospitalist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 11 | $671 |
| Cefdinir | 34 | $271 |
| Doxycycline Hyclate | 21 | $191 |
| Pantoprazole Sodium | 21 | $144 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $103 |
| Ondansetron Hcl | 15 | $103 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $102 |
| Furosemide | 38 | $97 |
| Azithromycin | 18 | $92 |
| Atorvastatin Calcium | 15 | $65 |
| Prednisone | 27 | $62 |
| Metoprolol Tartrate | 11 | $55 |
| Metoprolol Succinate | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Reno
- Patrick WoodardReno$20K
- Sarah KianiReno$4K
- John EdwardsReno$2K
- Mohammad HanifReno$1K
- Catherine KarnoReno$759
- Paul ParkReno$751
- Amanda WagnerReno$734
- Brendan BirdReno$714
- William ValcheckReno$635
- Kimberly CowenReno$629
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.